Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
BETHLEHEM, Pa. – The Bethlehem Planning Commission on Thursday approved a plan for the expansion of Bosch Rexroth's Bethlehem campus at 2300 City Line Road. Bosch Rexroth proposed constructing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results